S&P 및 Nasdaq 내재가치 문의하기
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← 전체 종목으로

Immunovant, Inc. IMVT NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
47/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$35.67
+30%

Balance sheet is a point-in-time snapshot. TTM shows the most recent available quarter.

지표 Latest Quarter (2025-12)
총자산 $1.05B
Total Liabilities $66.26M
총부채 $0.00
Cash & Investments $994.53M
주주자본 합계 $986.14M

다른 사용자도 조회

KRTX
KRTX
Karuna Therapeutics, Inc.
$329.83
+0.03%
 MDGL
MDGL
Madrigal Pharmaceuticals, Inc.
$518.58
-1.22%
 BPMC
BPMC
Blueprint Medicines Corporation
$129.46
+0.14%
 PTGX
PTGX
Protagonist Therapeutics, Inc.
$105.44
+0.69%
 ACLX
ACLX
Arcellx, Inc.
$115.00
+0.10%
 ISEE
ISEE
IVERIC bio, Inc.
$39.95
+0.38%
 APLS
APLS
Apellis Pharmaceuticals, Inc.
$40.85
-0.01%
 AKRO
AKRO
Akero Therapeutics, Inc.
$54.65
+0.00%
문의하기
🎓
SharesGrow 아카데미
내재가치 계산법과 저평가 종목 찾기를 배우세요.
주간 라이브 세션
📧 [email protected]
📞 +65 8912 8000
메시지 보내기